CD8A and depressive symptom measurement: Particularly in the light of a recent study by Smolders and colleagues who reported a consistent brain-resident CD8+ T cell population in a miscellaneous autopsy cohort of patients with neurological disorders excluding brain malignancies (Alzheimer’s disease, Parkinson’s disease, dementia, depression, multiple sclerosis), as well as patients with no known brain disease.